Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Nucleai

Nucleai

An artificial intelligence company with a focus on developing solutions for the healthcare industry. It was founded in 2017 and is located in Tel Aviv, Israel.

About

Nucleai is a Tel Aviv-based company that uses artificial intelligence to design and create solutions for the healthcare industry, specifically for cancer diagnostics. It has the stated goal to improve cancer diagnostics making it accurate, effective, accessible and efficient in order to treat patients better by using machine learning, deep learning, and machine vision technology.

Product

The company's products are cloud-based and can be used to extract unique information from biopsies to better match the right patient to the right treatment and aid the pathologist in their findings. They can be used for colon, stomach, breast, and prostate biopsies. One of its products is pathology automation, which consists of the structuring and qualification of tissue images. Its other product is treatment prediction, which utilizes biomarkers and artificial intelligence to anticipate the optimal treatment for a cancer patient.The products also use data that has been extracted from Israeli hospitals in order to make predictions.

Timeline

July 2020
Nucleai raises a $6,500,000 series A round from Debiopharm Innovation Fund, Grove Ventures and Vertex Ventures Israel.
June 7, 2020
Nucleai raises a $6,500,000 series A round.
March 5, 2018
Nucleai has a seed round of funding.

The company raises $5 million in a seed round of funding. The round was led by Israeli-based venture capital funds Vertex Ventures Israel and Grove Ventures as well as private investors Brian Cooper and entrepreneur Nir Kalkstein .

March 2018
Nucleai raises a $5,000,000 seed round from Grove Ventures, Nir Kalkstein and Vertex Ventures Israel.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

How Nucleai is using AI to change healthcare

Web

How Nucleai is using AI to change healthcare

Web

November 27, 2019

Israeli AI Pathology System Startup Nucleai Raises $5M | News Briefs

Web

March 5, 2018

Nucleai

Web

1631566800000

This Israeli startup leverages AI to help pathologists handle their workload - MedCity News

Erin Dietsche

Web

April 10, 2019

References

Golden logo
By using this site, you agree to our Terms & Conditions.